Background: In response to DNA damage, cells activate checkpoints to halt cell-cycle progression and prevent genomic instability. Checkpoint activation induced by DNA double-strand breaks (DSB) is dependent on the ATM kinase, a master regulator of the DNA damage response (DDR) that is activated through autophosphorylation and monomerization. Results: Here we show that either protein phosphatase 1 or 2A is sufficient to suppress activation of the DDR and that simultaneous inhibition of both phosphatases fully activates the response. PP1-dependent DDR regulation is mediated by its chromatin-targeting subunit, Repo-Man. Studies in Xenopus egg extracts demonstrate that Repo-Man interacts with ATM and PP1 through distinct domains, leading to PP1-dependent regulation of ATM phosphorylation and activation. Consequently, the level of Repo-Man determines the activation threshold of the DNA damage checkpoint. Repo-Man interacts and extensively colocalizes with ATM in human cells. Expression of wild-type, but not PP1 binding-deficient, Repo-Man attenuates DNA damage-induced ATM activation. Moreover, Repo-Man dissociates from active ATM at DNA damage sites, suggesting that activation of the DDR involves removal of inhibitory regulators. Analysis of primary tumor tissues and cell lines demonstrates that Repo-Man is frequently upregulated in many types of cancers. Elevated Repo-Man expression blunts DDR activation in precancerous cells, whereas knockdown of Repo-Man in malignant cancer cells resensitizes the DDR and restrains growth in soft agar. Conclusions: We report essential DDR regulation mediated by Repo-Man-PP1 and further delineate underlying mechanisms. Moreover, our evidence suggests that elevated Repo-Man contributes to cancer progression.
Introduction
To protect genomic integrity after DNA damage, cells have evolved surveillance mechanisms, generally termed the ''DNA damage response (DDR),'' that encompass both DNA repair and signal transduction pathways, activating cell-cycle checkpoints and arresting cell-cycle progression [1, 2] . The DDR to DNA double-strand break (DSB) is initiated by activation of the ataxia telangiectasia mutated (ATM) Ser-Thr kinase, which triggers multiple mechanisms of signal amplification. Activation of ATM involves intermolecular autophosphorylation so that a small pool of activated ATM at the site of DSBs rapidly induces ATM autophosphorylation throughout the cell [3] . Moreover, ATM anchoring to chromatin by g-H2AX and adaptors, such as Mdc1 and the Mre11-Rad50-Nbs1 complex, results in expansion of H2AX phosphorylation to large chromatin regions flanking DSBs [4] . A potential consequence of these amplification mechanisms is that minimal DNA damage may eventually cause full activation of the DDR. However, recent studies indicate that a threshold level of DNA damage has to be reached for the checkpoint to affect cell-cycle progression. In Xenopus, 2-4 ng/ml of damaged DNA is required to elicit DNA damage checkpoint signaling in egg extracts and to slow cleavage cycles in embryos [5, 6] . Similarly, a defined G2/M checkpoint threshold of 10-20 DSBs per cell has been reported in human cells, and DNA damage below that threshold level neither efficiently activates the checkpoint nor sustains it prior to completion of DNA repair [7, 8] . It is currently unclear how DNA damage thresholds are achieved and regulated; a credible speculation is that cells have evolved inhibitory mechanisms to prevent checkpoint activation by a subthreshold level of DNA damage.
Recently, several Ser-Thr protein phosphatases have been found responsible for deactivation of the DNA damage checkpoint during recovery from cell-cycle arrest [9] [10] [11] . A wellstudied example is PP2Cd/Wip1, which has been shown to dephosphorylate multiple phospho-S/TQ sites targeted by ATM or ATR, including those in ATM itself and its substrates [12, 13] . Also connected to the checkpoint recovery pathway are PP1 and PP2A, which together account for 95% of total cellular Ser-Thr phosphatase activity. Unlike Wip1 or other PP2C family members, specific functions of PP1 and PP2A are conferred by additional targeting subunits that control their subcellular localization and substrate specificity [10, 11] . Studies in yeast and mammalian cells show that specific PP2A and PP4 (PP2A-like) complexes are responsible for g-H2AX dephosphorylation during checkpoint recovery [14] [15] [16] . The involvement of PP1 in checkpoint recovery is less well studied, but in S. pombe, dephosphorylation of Chk1 by Dis2 (a PP1 homolog) allows mitotic entry upon completion of DNA repair in G2 [17] . The specific targeting subunit in yeast or higher eukaryotes that mediates PP1 regulation of DDR factors has yet to be identified.
Given that activation of the DDR relies on protein phosphorylation by ATM and other kinases, it is possible that protein phosphatases, particularly PP1 and PP2A, create a sensitivity threshold for DNA damage checkpoint activation in addition to promoting checkpoint recovery. In this study, we show that the chromatin-bound Repo-Man-PP1g complex modulates ATM activation, thereby setting the threshold for checkpoint activation. Importantly, Repo-Man (recruits PP1 onto mitotic chromatin at anaphase, also known as Cdca2) is frequently upregulated in various cancers, and overexpression is both necessary and sufficient for reduced DDR sensitivity during cancer progression. Reduction of Repo-Man expression attenuates growth of breast cancer cells in soft agar, arguing that upregulation of Repo-Man is essential for anchorage-independent growth of at least some tumor cells.
Results

PP1
and PP2A Both Regulate DNA Damage Response Activation PP1 and PP2A are the two major forms of Ser-Thr phosphatase in Xenopus egg extracts [18, 19] . To investigate whether PP1 and PP2A are required to suppress DDR activation, we utilized microcystin-LR (MC) to inhibit PP1 and PP2A phosphatases in undamaged Xenopus egg extracts, which have been widely used to study the DDR [20, 21] . Quite strikingly, MC induced robust phosphorylation of Smc1, H2AX, Chk1, Chk2, and Mre11, as judged by phospho-antibody blotting or retarded electrophoretic mobility ( Figure 1A ). Okadaic acid (OA) at 2 mM inhibits most PP2A and PP1 activity [18, 22] and was sufficient to activate responses similar to those induced by MC ( Figure 1A ). In contrast, OA at 0.4 mM that inhibits only PP2A activity [18, 22] , or Inhibitor-2 (I-2) at 0.4 mM that specifically inhibits PP1 [23] , did not elicit significant activation of Smc1, Chk1, Chk2, or Mre11 phosphorylation, despite minimal H2AX phosphorylation ( Figure 1A ). Interestingly, extracts treated with both OA at 0.4 mM and I-2 exhibit strong phosphorylation of Smc1, Chk1, Chk2, H2AX, and Mre11 (Figure 1A) . Taken together, these results indicate that both PP1 and PP2A are involved in DDR regulation. Either PP1 or PP2A alone is sufficient to suppress spontaneous DDR activation, and inhibition of both phosphatases synergistically induces DDR signaling without actual DNA damage. The critical involvement of PP1 in DDR regulation is also supported by evidence that PP1 inhibition sensitizes DDR activation. When Xenopus egg extracts were supplemented with I-2 to inhibit PP1, we observed an elevated response to low-dose DNA damage, added as either cut plasmid DNA ( Figure 1B ) or double-stranded oligonucleotides ( Figure 1C ).
Repo-Man Recruits PP1 to Chromatin to Suppress DNA Damage Response Activation MC-induced Chk2 and Chk1 phosphorylation was more pronounced in extracts supplemented with sperm DNA (see Figure S1A available online), which itself is undamaged and does not activate the checkpoint on its own [6] . The DNA dependence of MC-induced Chk1 and Chk2 phosphorylation suggests that inhibition of protein phosphatases produces chromatin-based signal transduction like that induced by actual DNA damage [24] . An attractive hypothesis is that a chromatin-bound protein phosphatase suppresses DDR activation and that its inhibition promotes DDR signaling on chromatin. The g isoform of PP1 has been reported to be present on chromatin [25] , and we confirmed that a portion of PP1g binds to chromatin in Xenopus egg extracts, whereas neither PP1a nor PP2A were detectable on chromatin ( Figure S1B ). To investigate the relevance of PP1g to activation of the DNA damage checkpoint, we immunodepleted PP1g from egg extracts and observed that the extracts became more sensitive to DNA damage, whereas add-back of recombinant PP1g abolished the hypersensitivity (Figures 2A  and 2B ). These results suggest that PP1g is involved in suppression of DNA damage signaling.
Unlike other protein phosphatases, specific functions of PP1 are achieved through interactions with targeting subunits that contain a consensus PP1-interacting motif, RVxF [10] . A PP1g-specific interacting protein, Repo-Man, has been reported to recruit PP1g onto mitotic chromosomes [26, 27] . The interaction between Repo-Man and PP1g persists through interphase, implying that Repo-Man could also be responsible for chromatin localization of PP1g in interphase [26] . We cloned the Repo-Man homolog in Xenopus (GenBank accession number FJ532285) and raised an antibody against its C terminus ( Figures S2A-S2C ). Affinity-purified PP1g antibody coimmunoprecipitated Repo-Man from interphase egg extracts, confirming interaction between PP1g and RepoMan in Xenopus ( Figure S2D ). Furthermore, specific chromatin binding of PP1g and Repo-Man was evident in Xenopus egg extracts ( Figure S2G ), whereas knockdown of endogenous Repo-Man with antisense oligonucleotides ( Figure S2C ) or disruption of Repo-Man-PP1g interaction with a consensus RVTF peptide ( Figures S2E and S2F ) reduced binding of PP1g to chromatin ( Figure S2H ). We thus confirm in Xenopus that Repo-Man interacts with PP1 through its RVTF motif and recruits PP1 onto chromatin. Importantly, addition of the RVTF peptide, but not the control RATA peptide, led to Chk1 and Smc1 phosphorylation with a lower dose of damaged DNA ( Figure 2C ). In addition, expression of a mutant RepoMan, in which the RVTF motif was changed to RATA, also reduced PP1 association ( Figure 3A ) and enabled Smc1 phosphorylation with a lower amount of damaged DNA ( Figure 2D ). The enhanced response was DNA damage induced and caffeine sensitive, confirming that it results from ATM-or ATRdependent signal transduction ( Figure 2D ). Moreover, reducing the level of Repo-Man expression with two different antisense oligonucleotides increased sensitivity to DNA damage in a fashion correlated with the efficiency of the knockdown (Figure 2E) . Conversely, ectopic expression of Repo-Man suppressed DNA damage-induced signaling in egg extracts, as shown by phosphorylation of Smc1 ( Figure 2F ). To assess DNA damage checkpoint activation by induction of cell-cycle arrest in vivo, we studied progesterone-induced Xenopus oocyte maturation, a model of the G2/M transition. Injection of damaged DNA activated the checkpoint and blocked the transition to M phase ( Figure S2I ). When the Repo-Man level was reduced by antisense oligonucleotides, the minimal amount of DNA damage required to affect cell-cycle progression was lowered, whereas oocytes with overexpressed Repo-Man underwent maturation despite the presence of DNA damage at doses sufficient to activate the checkpoint in control oocytes ( Figure 2G ). Therefore, these results establish Repo-Man as a negative regulator of the DDR. By targeting PP1g to chromatin to inhibit checkpoint signaling, Repo-Man dictates the cellular response to low-dose DNA damage and sets a threshold for checkpoint activation.
Repo-Man Targets PP1 to Modulate ATM Activation Among components of the DNA damage signaling pathway, especially those that bind to chromatin, we observed that ATM, but not Chk1 or H2AX, was copurified from egg extracts in a pull-down assay with His-tagged Repo-Man, wild-type or mutated in the PP1 binding site ( Figures 3A and 3B ), suggesting that Repo-Man association with ATM is independent of its association with PP1. The extracts were not supplemented with sperm DNA, and thus Repo-Man-PP1 association is not mediated by chromatin. The interaction was confirmed with endogenous Repo-Man and ATM coimmunoprecipitation in Xenopus egg extracts ( Figure 3C ). The ATM-interacting domain of Repo-Man was mapped to its C terminus, whereas the middle part of Repo-Man, which contains the RVTF motif, was sufficient to bind PP1g ( Figure 3D ). By binding to PP1g in one region of the molecule and to ATM in another, Repo-Man acted as a bridge for PP1-ATM interaction, which was reduced in extracts with Repo-Man knockdown ( Figure S3A ). In light of DDR regulation by protein phosphatases, we speculate that Repo-Man brings PP1g adjacent to ATM, leading to regulation of ATM. ATM autophosphorylated at Ser 1981 was efficiently dephosphorylated by PP1g in vitro ( Figure S3B ), and, more importantly, extracts with a reduced level of Repo-Man exhibited augmented ATM autophosphorylation with or without DNA damage ( Figure 3E , top). Consistently, ATM kinase activity in extracts was enhanced by Repo-Man knockdown ( Figure 3E , bottom). Taken together, our evidence pinpoints ATM as a key substrate of the Repo-Man-PP1g enzymatic complex.
Repo-Man Is Associated and Colocalized with ATM and Regulates ATM Activation in Human Cells
The interaction between ATM and Repo-Man identified in Xenopus egg extracts ( Figures 3A-3D ) is conserved in human cells. As shown in Figure 4A , Repo-Man coimmunoprecipitated with ATM in nontumorigenic human MCF10A epithelial cells. To study the subcellular localization of ATM and Repo-Man, we first extracted MCF10A cells to remove soluble but not chromatin-bound proteins and then immunostained for ATM or Repo-Man. Chromatin-bound ATM extensively colocalized with Repo-Man ( Figure 4B ). Generation of chromatin fibers provided higher resolution for studying chromatin localization of proteins, and the same pattern of chromatin distribution was observed for ATM and Repo-Man on chromatin fibers ( Figure 4C ). The specificity of the Repo-Man immunostaining of cells and chromatin fibers was confirmed in Figure S4 . Our studies in Xenopus egg extracts and oocytes show that Repo-Man targets PP1 to regulate ATM phosphorylation and activation ( Figure 2 ). This function is also conserved in human cells. Ectopic expression of Repo-Man tagged by GFP reduced etoposide-induced ATM activation, as judged by the different level of ATM autophosphorylation at Ser 1981 in GFP-positive and control cells ( Figure 4D , top). In agreement with the PP1 dependence of this regulation, similar expression of a PP1 binding-deficient Repo-Man mutant (AA), in which the RVTF binding motif was mutated to RATA, did not reduce DNA damage-induced ATM activation, but instead further stimulated the response ( Figure 4D , bottom).
Repo-Man Is Dissociated from Active ATM at DNA Damage Sites In Xenopus egg extracts, chromatin association of both RepoMan and PP1g was reduced by high-dose Neocarzinostatin (NCS), a DNA-damaging agent known to cause DSBs on genomic DNA [28] (Figure 5A ). On the other hand, chromatin binding of ATM increased after DNA damage, possibly reflecting recruitment to DNA damage sites ( Figure 5A) . A similar dissociation of Repo-Man from chromatin after DNA damage was observed in MCF10A cells ( Figure 5B ). An interesting hypothesis is that release of Repo-Man near DNA damage sites facilitates activation of the DDR, and consequently, active ATM at DNA damage sites may not be associated with or inhibited by Repo-Man. To test this idea, we subjected MCF10A cells to DNA damage, extracted them to remove soluble proteins, and immunostained the residual chromatin for active ATM and Repo-Man. In contrast to extensive colocalization between ATM and Repo-Man in unperturbed cells ( Figures 4B and 4C) , Repo-Man did not colocalize with active, phosphorylated ATM ( Figure 5C ). Measurement of fluorescence intensity further suggests that the level of Repo-Man was generally reduced at foci where active ATM was concentrated ( Figure 5C , bottom). These foci have been shown to reflect DNA damage sites where many DDR factors are recruited [29] , and thus the removal of Repo-Man from these areas supports our hypothesis. Another line of supporting evidence was provided by immunostaining of chromatin fibers. As previously shown [30] , double-strand breaks are not directly visible but can be marked on chromatin fibers by detection of DDR factors. Interestingly, Repo-Man is excluded from chromatin domains enriched with active ATM (Figure 5D ). Dissociation of Repo-Man from active ATM was also directly monitored by immunoprecipitation with phospho-specific ATM pS1981 antibody. As shown in Figure 5E , Repo-Man did not coimmunoprecipitate with phospho-ATM in DNA damage-treated cells. 
Expression of Repo-Man Is Frequently Elevated in Cancer Cells
Repo-Man was first identified as a gene whose expression correlates with known cell-cycle genes [31] . More recently, it has been classified by two independent high-throughput screens into a unique group of genes that are upregulated during progression of neuroblastomas and melanomas [32, 33] . These results prompted us to test whether Repo-Man overexpression is generally evident during cancer progression. Using immunohistochemistry, we observed enhanced expression of Repo-Man in many, but not all, cancer tissues as compared to adjacent normal tissues ( Figures S5A and S5B ). As summarized in Figure S5C , significantly increased RepoMan expression was found in roughly half of all cancer tissues tested. To extend this analysis, we obtained a series of staged and graded human breast tumors and matched normal tissues.
As shown in Figure S5D , analysis in these tissue lysates shows that Repo-Man was frequently overexpressed in late stage and higher-grade tumors. Consistently, Repo-Man level was also elevated in a panel of tumorigenic breast cancer cell lines compared to nontumorigenic lines (Figure S5E) . Finally, the National Cancer Institutesupported mRNA expression database (http:// www.oncomine.org;) shows that Repo-Man transcription is frequently upregulated in various cancers ( Figure S5F ). We thus speculate that increased Repo-Man levels during cancer progression result at least partly from activated gene transcription. Taken together, a comprehensive set of evidence shows that Repo-Man is overexpressed in a large proportion of late-stage cancers.
Elevated Repo-Man Expression Blunts the DNA Damage Response during Cancer Progression
To investigate whether overexpression of RepoMan renders early-stage tumor cells less sensitive to DNA damage, we analyzed the well-established MCF10A human breast cancer model system consisting of a series of transformed mammary epithelial cell (MEC) lines that share a common genetic ancestry. Each line represents a distinct stage of breast cancer development, ranging from normal (i.e., MCF10A) to premalignant (i.e., MCF10A-T1k) to malignant (i.e., MCF10A-CA1h) to invasive and metastatic (i.e., MCF10A-CA1a) [34] . These lines can be studied in cell culture and also as human tumor xenografts in nude mice. Extensive gene array, SAGE, and single-nucleotide polymorphism analyses have indicated that this system accurately recapitulates the genetic changes that are found during human breast cancer progression [35, 36] . Interestingly, expression of Repo-Man is greatly elevated during the transition from T1k to CA1h, as confirmed by both immunofluorescence and western blotting (Figures 6A and 6B ). In concert with this change in Repo-Man level, the DDR to etoposide in malignant CA1h cells is less sensitive than that in premalignant T1k cells, as judged by both phosphorylation of DDR components and G2/M arrest ( Figures 6C and 6D) . Importantly, ectopic expression of Repo-Man significantly reduced the DDR in T1k cells to the CA1h level ( Figures 6E and 6F) , indicating that upregulation of Repo-Man is sufficient for the reduced DDR in CA1h cells. Conversely, knockdown of Repo-Man expression resensitized the DDR in late-stage cancer cells, including CA1h ( Figure 6G ) and CA1a in the MCF10A breast cancer model, and also in BT-20, a well-established breast cancer cell line initially derived from an advanced invasive ductal carcinoma ( Figure S6A ). These results confirm the critical role of Repo-Man in modulating DNA damage signaling.
Repo-Man Expression Is Required for CA1h Cell Growth in Soft Agar
To assess whether upregulation of Repo-Man is necessary to promote tumorigenesis, we studied growth of tumor cells in soft agar assays. Malignant CA1h cells grow into large colonies in soft agar, whereas precancerous T1k cells only form very small ones. Interestingly, CA1h cells stably infected with lentiviral small hairpin RNA (shRNA) that knocks down RepoMan expression were unable to form large colonies in soft agar ( Figure 7A ; Figure S6B ), despite little effect on proliferation in regular culture. On the other hand, ectopic expression of Repo-Man was not sufficient to promote soft agar growth of T1k, although some increase in colony size was evident ( Figures 7B and 7C) . Therefore, upregulation of Repo-Man is necessary but not sufficient for anchorage-independent/soft agar growth in the MCF10A breast cancer model.
Discussion
Serine/threonine phosphatases are less studied compared to their functional counterparts, serine/threonine kinases. Both PP1 and PP2A rely on additional targeting subunits to perform specific functions. Recent publications have begun to identify these targeting subunits and the underlying mechanisms and to present an attractive picture in which the complexity, specificity, and importance of protein phosphatases are generally comparable to that of protein kinases [10, 11] . In the DDR pathway, several groups of protein phosphatases have been shown to dephosphorylate DDR components and promote recovery from checkpoint arrest. Some key questions, however, remain to be answered. For example, do protein phosphatases regulate the initial activation of the DDR, and how is regulation specifically achieved? In this study, we show that inhibition of PP1 and PP2A efficiently turns on DDR signaling in Xenopus egg extracts. These findings underscore the essential role of both PP1 and PP2A in suppression of the DDR. The involvement of PP2A reported here supports its previously revealed role as an important DDR regulator that promotes checkpoint recovery through dephosphorylation of multiple DDR factors, including H2AX, Chk2, Chk1, ATM, and p53, etc. [9, [14] [15] [16] . Data presented here clearly indicate that PP1 also plays a critical role in DDR regulation. Inhibition of PP2A or PP1 alone is not sufficient to activate DDR signaling, but simultaneous inhibition of both phosphatases fully turns on the DDR. Moreover, inhibition of PP1 results in a sensitized response to DNA damage. This study reveals the first specific PP1-dependent regulation of the DDR mediated by a chromatin-bound targeting subunit, Repo-Man. Importantly, Repo-Man interacts with PP1 and ATM through distinct motifs, thus targeting PP1g to antagonize ATM activation and negatively regulate DNA damage-induced signal transduction. In this scenario, Repo-Man controls both the localization and substrate specificity of the PP1 holoenzyme complex and sets the threshold for checkpoint activation in both Xenopus oocytes and egg extracts ( Figure 7D ). The functional relationship between ATM and Repo-Man was further strengthened by studies in human cells. Repo-Man associates with ATM and extensively colocalizes with ATM on chromatin.
Overexpression of Repo-Man in cells reduces DNA damageinduced ATM activation, whereas a PP1 binding-deficient Repo-Man dominant-negative mutant enhances the response. Another important question regarding specific phosphatase complexes is how they are regulated by DNA damage. We report here that Repo-Man is released from DNA damage sites and dissociated from active ATM, presumably to facilitate DDR activation by DNA damage above the threshold level. This is a striking result because it argues that activation of the DDR involves removal of inhibitory regulators. Though the underlying mechanism is unclear, the chromatin dissociation of Repo-Man-PP1 may be phosphorylation dependent, because MC treatment removed PP1 and Repo-Man from chromatin (data not shown). The DDR pathway is essential to protect genomic stability and suppress tumorigenesis. Inherited mutations in DDR factors, including ATM, Chk1, Chk2, Mre11, Nbs1, etc., predispose patients to various cancers. However, most cancer patients are born with an intact DDR pathway, and little is known about how their tumor cells escape from the DDR. Recent reports show that the DDR is activated in early, precancerous cells as a barrier to suppress cell proliferation and cancer progression [2] . DDR activation is greatly reduced in late-stage cancer cells, presumably resulting in uncontrolled cell proliferation [2, 37, 38] . The mechanism of this modulation in DNA damage responsiveness is unknown. Our study presented here discovered a mechanism that may contribute to this process. We found that Repo-Man expression is significantly enhanced in many, although not all, cancers. Repo-Man overexpression is sufficient to modulate DDR sensitivity during progression of cancer because elevated Repo-Man blunted the DDR in early-stage precancerous cells and, conversely, knockdown of Repo-Man restored DDR sensitivity in advanced-stage cancer cells. We propose that during early stages of cancer progression, the DDR is activated in response to elevated genomic instability to prevent further cell proliferation. Such a process poses a selection pressure for cells with a reduced DDR, such as those in which Repo-Man is upregulated. These cells resume proliferation bearing a high level of spontaneous DNA damage, resulting in acquisition of additional mutations and further cancer progression. The involvement of Repo-Man in cancer progression is supported by the soft agar assay showing that Repo-Man expression is essential for colony formation. However, several aspects of this model still remain to be further clarified. For example, it is unclear whether RepoMan upregulation is a consequence of oncogenic stimuli. Moreover, although not all cancers exhibit Repo-Man overexpression, a similar deregulation of the DDR could be achieved in some cancers through parallel mechanisms that involve other protein phosphatase complexes [12, 14, 16, 39] . Of particular interest to us, inhibition of PP1, PP2A, or PP2Cd/ Wip1 has been shown to affect cell survival post radiation or after chemotherapy (reviewed in [40] ). We report here that merely reducing Repo-Man expression resensitized advanced cancer cells to the DDR and restrained their growth, suggesting that Repo-Man may be a potentially valuable target in cancer therapy.
Experimental Procedures
cDNA Cloning of Xenopus Repo-Man Total RNA was extracted from Xenopus laevis oocytes with a QuickPrep total RNA extraction kit (Amersham) following the protocol recommended by the manufacturer. The 5 0 and 3 0 sequences of Xenopus Repo-Man were determined by rapid amplification of cDNA ends (RACE) with a SMART RACE cDNA amplification kit (Clontech). The full-length cDNA of Xenopus Repo-Man was then generated by end-to-end polymerase chain reaction (with primers 5 0 -ATCTCCAGAAAGGTTTTGCAGGAG-3 0 and 5 0 -AATGTAA CGGTCCATGGGTTCTGC-3 0 ). The sequence has been deposited in GenBank under accession number FJ532285.
Cell Extraction and Chromatin Fiber
Cell extraction was carried out via a protocol described previously, with minor modifications [41] . Cells on coverglasses were treated with extraction buffer (0.5% NP40 in phosphate-buffered saline [PBS]) for 5 min on ice and washed once with extraction buffer and twice with PBS. Immunostaining was then performed as described below. Chromatin fibers were generated following a previously established protocol [42] . Briefly, 2 3 10 5 cells were resuspended in 0.5% sodium citrate for 10 min and spun onto a coverglass. The coverglass was then dipped in salt/detergent buffer (25 mM Tris 7.5, 500 mM NaCl, 1% Triton X-100) for 10 min and removed for immunostaining.
Chromatin Fractionation
As described previously [6] , to reisolate sperm chromatin from egg extracts, extracts were diluted 10-fold with chromatin dilution buffer (50 mM HEPES, pH 7.5, 50 mM KCl, 5 mM MgCl 2 , 2 mM DTT, 0.5 mM spermine 3 HCl, 0.15 mM spermine 4 HCl, 0.1% Triton X-100). The diluted extract was then layered onto 3 ml of chromatin dilution buffer containing 30% sucrose and centrifuged at 6000 3 g for 15 min. The pellet was resuspended as the chromatin-enriched fraction.
Repo-Man Knockdown
Small interfering RNA (siRNA) duplexes targeting human Repo-Man (target sequences UCAGAAGCAUGCCGAAUUA and GUUCAAAGGCUACCGGA GA) and a nontargeting control siRNA were purchased from Dharmacon and transfected into CA1h, CA1a, or BT-20 cells, following the protocol recommended by the manufacturer. Lentiviral shRNAs targeting Repo-Man were utilized to infect CA1h cells, following the protocol recommended by the manufacturer (Sigma, NM_152562). Morpholino antisense oligonucleotides targeting Xenopus Repo-Man were designed and produced by Gene Tools. Both morpholino oligonucleotides (TCTGGAAGTCATCACCT CCTCTCCA and AGATTCAAATTCAAATCTGCCGCCG) were suspended in nuclease-free water to a concentration of 0.1 mM, and 40 nl was injected into each oocyte.
Soft Agar Assay
The growth of T1k and CA1h cells in soft agar was performed as described [43] . In brief, cells (10,000 cells per plate) were grown in 0.3% agar on a cushion of 0.6% agar in 35 mm plates for 14 days, after which the colonies were observed under a light microscope.
Xenopus Oocytes and Cytostatic Factor Extracts
Oocyte maturation was induced in vitro by addition of progesterone (10 mg/ml), and entry into M phase was monitored by germinal vesicle breakdown with a dissecting microscope, as described previously [6] . Cytostatic factor extracts, prepared as previously described [6] , were stably released into interphase by supplementation with 0.4 mM CaCl 2 and 100 mg/ml cycloheximide, followed by incubation for 30 min at room temperature prior to use. Oocyte extracts were generated by homogenization of the oocytes, followed by centrifugation at 15,000 3 g for 4 min at 4 C. NCS was purchased from Sigma and used to generate DNA DSBs in extracts at concentrations indicated in the figure legends. Extracts used in this study were supplemented with 1,000 demembranated sperm nuclei/ml, unless otherwise indicated. I-2 and MC were purchased from New England Biolabs and Calbiochem, respectively.
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